Bengaluru Oct 26 (IANS) Biotechnology major Biocon Ltd on Thursday reported Rs 69 crore consolidated net profit for the second quarter (Q2) of fiscal 2017-18 which is a 53 per cent decline from Rs 147 crore in the same period a year ago.
In a regulatory filing on the BSE the city-based leading drug maker said consolidated revenue from operations marginally grew 2 per cent to Rs 969 crore in the quarter under review (Q2) from Rs 955 core in the like period year ago.
Sequentially too net income declined 15 per cent from Rs 81 crore while revenue increased modestly 4 per cent from Rs 934 crore quarter ago.
Earnings before interest tax depreciation and amortisation (Ebitda) also declined 16 per cent annually to Rs 233 crore for Q2 from Rs 278 crore year ago and down five per cent from Rs 246 crore quarter ago.
"Research and Development (R&D) expense declined 17 per cent annually to Rs 93 crore for Q2 from Rs 113 crore in same quarter year ago " added the filing.
--IANS
fb/pgh/bg
